These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 11351306

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and selectivity of vindesine monoclonal anti-carcinoembryonic antigen antibody conjugates on human tumor cell lines grown as xenografts in nude mice.
    Casson AG, Ford CH, Marsden CH, Gallant ME, Bartlett SE.
    NCI Monogr; 1987; (3):117-24. PubMed ID: 3821911
    [Abstract] [Full Text] [Related]

  • 5. Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alpha.
    Robert B, Mach JP, Mani JC, Ychou M, Folli S, Artus JC, Pèlegrin A.
    Cancer Res; 1996 Oct 15; 56(20):4758-65. PubMed ID: 8840995
    [Abstract] [Full Text] [Related]

  • 6. Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.
    Gautherot E, Kraeber-Bodéré F, Daniel L, Fiche M, Rouvier E, Saï-Maurel C, Thedrez P, Chatal JF, Barbet J.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3177s-3182s. PubMed ID: 10541361
    [Abstract] [Full Text] [Related]

  • 7. Production of hybrids secreting bispecific antibodies recognising CEA and doxorubicin.
    Reddy VS, Ford CH.
    Anticancer Res; 1993 Oct 15; 13(6A):2077-83. PubMed ID: 8297116
    [Abstract] [Full Text] [Related]

  • 8. Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
    Kraeber-Bodéré F, Faibre-Chauvet A, Saï-Maurel C, Gautherot E, Fiche M, Campion L, Le Boterff J, Barbet J, Chatal JF, Thédrez P.
    J Nucl Med; 1999 Jan 15; 40(1):198-204. PubMed ID: 9935077
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor Killing.
    Lehmann S, Perera R, Grimm HP, Sam J, Colombetti S, Fauti T, Fahrni L, Schaller T, Freimoser-Grundschober A, Zielonka J, Stoma S, Rudin M, Klein C, Umana P, Gerdes C, Bacac M.
    Clin Cancer Res; 2016 Sep 01; 22(17):4417-27. PubMed ID: 27117182
    [Abstract] [Full Text] [Related]

  • 11. Carcinoembryonic antigen regulation in human colorectal tumor cells by a site-selective cyclic AMP analogue: a comparison with interferon-gamma.
    Guadagni F, Tortora G, Roselli M, Clair T, Cho-Chung YS, Schlom J, Greiner JW.
    Int J Cancer; 1991 May 30; 48(3):413-22. PubMed ID: 1645700
    [Abstract] [Full Text] [Related]

  • 12. Novel doxorubicin-monoclonal anti-carcinoembryonic antigen antibody immunoconjugate activity in vitro.
    Lau A, Bérubé G, Ford CH, Gallant M.
    Bioorg Med Chem; 1995 Oct 30; 3(10):1305-12. PubMed ID: 8564396
    [Abstract] [Full Text] [Related]

  • 13. Affinity purification of novel bispecific antibodies recognising carcinoembryonic antigen and doxorubicin.
    Ford CH, Osborne PO, Mathew A, Rego BG.
    J Chromatogr B Biomed Sci Appl; 2001 Apr 25; 754(2):427-35. PubMed ID: 11339286
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A mouse/human-chimeric bispecific antibody reactive with human carcinoembryonic antigen-expressing cells and human T-lymphocytes.
    Kuwahara M, Kuroki M, Arakawa F, Senba T, Matsuoka Y, Hideshima T, Yamashita Y, Kanda H.
    Anticancer Res; 1996 Apr 25; 16(5A):2661-7. PubMed ID: 8917366
    [Abstract] [Full Text] [Related]

  • 16. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity.
    Awasthi S, Singhal SS, Singhal J, Yang Y, Zimniak P, Awasthi YC.
    Int J Oncol; 2003 Apr 25; 22(4):721-32. PubMed ID: 12632061
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.
    Garde SV, Forté AJ, Ge M, Lepekhin EA, Panchal CJ, Rabbani SA, Wu JJ.
    Anticancer Drugs; 2007 Nov 25; 18(10):1189-200. PubMed ID: 17893520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.